APA (7th ed.) Citation

C, H., Y, Z., X, C., Y, T., T, G., B, T., . . . T, C. (2026). A predictive model for low-dose rituximab response in anti-acetylcholine receptor antibody-positive myasthenia gravis: Establishment and validation. Frontiers in immunology, 17, 1781372. https://doi.org/10.3389/fimmu.2026.1781372

Chicago Style (17th ed.) Citation

C, Hou, Zhang Y, Cao X, Tang Y, Gao T, Tang B, Zhu Y, Ruan Z, and Chang T. "A Predictive Model for Low-dose Rituximab Response in Anti-acetylcholine Receptor Antibody-positive Myasthenia Gravis: Establishment and Validation." Frontiers in Immunology 17 (2026): 1781372. https://doi.org/10.3389/fimmu.2026.1781372.

MLA (9th ed.) Citation

C, Hou, et al. "A Predictive Model for Low-dose Rituximab Response in Anti-acetylcholine Receptor Antibody-positive Myasthenia Gravis: Establishment and Validation." Frontiers in Immunology, vol. 17, 2026, p. 1781372, https://doi.org/10.3389/fimmu.2026.1781372.